Skip to main content
OpenTrials

Clinical trial condition

Uterine Neoplasms

Explore clinical trials studying Uterine Neoplasms. Study availability and eligibility vary by location and protocol.

2,258 public trials 566 recruiting studies
Refine in advanced search Browse all conditions

Uterine Neoplasms trial results

Completed

Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for Endometrial Carcinoma (ENGOT-en9 / MK-7902-001) - China Extension Study

NCT04865289

Conditions
Endometrial Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Anhui Cancer Hospital-Gynecological Oncology ( Site 2509) Hefei, Anhui, China
  • Beijing Obstetrics and Gynecology Hospital Capital Medical University ( Site 2505) Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital ( Site 2501) Beijing, Beijing Municipality, China
  • Beijing Cancer Hospital ( Site 2504) Beijing, Beijing Municipality, China
View all 22 locations
View Trial Details
Completed

A Study to Investigate the Prevalence of Human Epidermal Growth Factor Receptor 2 (HER2) Immunohistochemistry (IHC) 3+ and Characterize the Clinicopathologic Features of Gynecologic Cancers in Taiwan

NCT06925113

Conditions
Adnexal Diseases, Cervical Cancers, Endocrine Gland Neoplasms, +20 more
Locations
  • Kaohsiung Chang Gung Memorial Hospital Kaohsiung City, Taiwan
  • Taichung Veterans General Hospital Taichung, Taiwan
  • National Taiwan University Hospital Taipei, Taiwan
  • Mackay Memorial Hospital Taipei, Taiwan
View Trial Details
Completed

Afuresertib +Sintilimab+Chemotherapy in Patients With Selected Solid Tumors That Resistance to Prior Anti-PD-1/PD-L1

NCT05383482

Conditions
Cervical Cancer, Digestive System Diseases, Digestive System Neoplasms, +24 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Chongqing Cancer Hospital Chongqing, Chengdu, China
  • Jilin Cancer Hospital Changchun, Jilin, China
  • Zhongshan Hospital, Fudan University Shanghai, Shanghai Municipality, China
View Trial Details
Completed

Atezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancer

NCT03738228

Conditions
Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, +21 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • UCHealth University of Colorado Hospital Aurora, Colorado, United States
View all 16 locations
View Trial Details

Related conditions